SEGRO signs lease contract with Kite, a Gilead company, at SEGRO Park Amsterdam Airport

SEGRO, an internationally operating investor and developer of logistics and industrial real estate, signed a long-term lease agreement with Kite, a Gilead company, that is engaged in the development of novel cancer immunotherapy products. Since March 1st, Kite has taken over 10,000 square meters at SEGRO Park Amsterdam Airport (SPAA).

For Kite, it is of great importance that their new facility complies with the highest standards. The property is set up in a very sustainable design and allows for a multifunctional use. For example, the building has been equipped with the latest solar panel technologies and a thermal energy storage system which stores heat or cold in the ground, so it will be possible to heat or cool the warehouse when needed. As a result, SEGRO complies with the BREEAM Excellent standard.

The proximity to Schiphol Airport and the Amsterdam metropole has been an important criterion to choose for SPAA as well. The optimum infrastructure, with direct connections to the A4/A5 motorways, rail and public transport make this location a prime logistics hotspot.

Growth in the future

Also, SPAA will offer Kite the opportunity to facilitate their future growth plans. At this moment, SEGRO is building the second phase, which is expected to be finalized by the end of 2018 and will consist of a variety of light industrial units. Later this year, SEGRO will also start the construction of another 10,000 square meters logistics unit at SPAA. The total scheme will comprise a total of over 100,000 square meters of logistics and industrial space. The fact that the building is newly built, highly sustainable and flexible in use are important aspects to Kite, seeing that they can fully adjust where necessary to meet their operations demands and needs.

Markwin Velders, VP Operations and Managing Director, Kite:

"Next to location, flexibility and the sustainability of the property, it is of great importance to us that our personalised cell therapies can be consistently manufactured in state-of-the-art facilities. All environmental factors must meet our high standards. We need to work with companies that look ahead like we do, and that is what SEGRO offers us. We therefore gladly start this collaboration and are looking forward to a long-term relationship."

Tijs Derison, Head of SEGRO Benelux, states the importance of this lease for SEGRO’s strategy in the Benelux:

"At SEGRO it is our purpose to create the space that enables extraordinary things to happen. It does not get any more extraordinary than this. We are proud to welcome Kite in our latest project and to facilitate them and collaborate in their strategy to bring life-saving therapies to cancer patients. It is always important to SEGRO to be able to respond to our customer’s needs. Therefore, we are happy to see we can respond to Kite Pharma’s demands in terms of building quality and sustainability. Also, the company expresses key values that meet our strategy: this company breaths the future, is innovative and holds sustainability in a very high regard.”

In this transaction, SEGRO was advised by JLL/CBRE and Stibbe. Kite was advised by Cushman&Wakefield and NautaDutilh.

……………………………………………………………………………………………………………….
Contact:
Kristien Siemons
T: +31 6 28 975 198
E: info@kristiensiemons.com
……………………………………………………………………………………………………………….

About SEGRO

SEGRO is a UK Real Estate Investment Trust (REIT), and a leading owner, manager and developer of modern warehouses and light industrial property. It owns or manages 6.4 million square metres (69 million square feet) of space valued at £8 billion, serving customers from a wide range of industry sectors. Its properties are located in and around major cities and at key transportation hubs in the UK and in nine other European countries.

See www.SEGRO.com and LinkedIn for further information.